Sedana Medical AB (publ)
SSE:SEDANA.ST
16.85 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -59.612 | -105.887 | -61.493 | -21.36 | -17.167 | -8.238 | -3.488 | 0.618 | -1.205 |
| Depreciation & Amortization
| 7.13 | 23.901 | 13.327 | 14.476 | 5.558 | 5.661 | 2.752 | 0.37 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | -1.412 | 0 | 0 |
| Change In Working Capital
| -20.929 | -35.325 | 11.588 | 0.433 | 2.374 | -3.018 | 4.728 | -0.599 | 0 |
| Accounts Receivables
| -6.254 | 7.494 | -2.169 | -15.292 | -6.663 | 2.32 | -6.249 | 0.54 | 0 |
| Inventory
| -6.738 | -27.504 | -2.296 | -1.158 | -1.077 | -3.079 | 1.331 | -0.641 | 0 |
| Accounts Payables
| -7.937 | -15.315 | 16.053 | 16.883 | 10.157 | -2.259 | 9.645 | -0.498 | 0 |
| Other Working Capital
| -7.937 | -15.315 | 16.053 | 16.882 | -0.044 | 0.061 | 3.397 | 0.042 | 0 |
| Other Non Cash Items
| 35.35 | 1.878 | -4.643 | -1.395 | 0.536 | -0.184 | -3.496 | -0.151 | 1.205 |
| Operating Cash Flow
| -38.061 | -115.433 | -41.221 | -7.846 | -8.7 | -5.779 | 0.496 | 0.238 | 0 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -168.888 | -137.783 | -110.255 | -84.619 | -54.132 | -29.127 | -25.882 | -4.928 | 0 |
| Acquisitions Net
| 321.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -465.417 | 0 | 0 | 0 | 0 | 0 | 0 | -0.651 | 0 |
| Sales Maturities Of Investments
| 312.348 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -321.442 | -137.048 | -105.063 | -72.175 | -49.839 | 0 | -22.106 | -4.066 | 0 |
| Investing Cash Flow
| -321.957 | -137.783 | -110.255 | -84.619 | -54.132 | -29.127 | -25.882 | -5.579 | 0 |
| Financing Activities: | |||||||||
| Debt Repayment
| -4.857 | -4.51 | -3.579 | -2.464 | -1.525 | 0 | -2.78 | -0.792 | 0 |
| Common Stock Issued
| 0 | 3.493 | 616.596 | 8.251 | 378.488 | 113.213 | 117.43 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.097 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -4.857 | 4.214 | -7.946 | 8.251 | -8.92 | -4.439 | -12.311 | 11.139 | 0 |
| Financing Cash Flow
| -4.857 | -1.507 | 605.071 | 5.787 | 368.044 | 108.774 | 102.34 | 10.347 | 0 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -11.687 | 26.283 | 6.415 | -1.711 | -0.002 | 0.161 | 0.072 | 0.119 | 0 |
| Net Change In Cash
| -376.562 | -228.439 | 460.01 | -88.389 | 305.209 | 74.029 | 77.025 | 5.124 | 0 |
| Cash At End Of Period
| 231.18 | 607.742 | 836.181 | 376.171 | 464.56 | 159.351 | 85.322 | 8.296 | 0 |